Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GHB vs. Trazodone for Memory Enhancement in MDD
NCT04082806Phase 2Completed
- Start
- Aug 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium oxybate in major depressive disorder (MDD). Started Aug 2020; status: completed.
02
Drugs
sodium oxybate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04082806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04082806.